We are live on
!
Find out more
RA
Royce & Associates Portfolio holdings
AUM
$12.4B
1-Year Est. Return
64.17%
This Fund
S&P 500
This Quarter
Est. Return
+6.61%
1 Year Est. Return
+64.17%
3 Year Est. Return
+130.04%
5 Year Est. Return
+162.55%
10 Year Est. Return
+785.5%
AUM
$14.5B
AUM Growth
+$172M
(+1.2%)
Cap. Flow
-$486M
Cap. Flow
% of AUM
-3.36%
Top 10 Holdings %
Top 10 Hldgs %
7.86%
Holding
1,321
New
67
Increased
464
Reduced
438
Closed
108
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PRA
ProAssurance
PRA
|
+$42.4M |
| 2 |
AL
Air Lease Corp
AL
|
+$29.6M |
| 3 |
Comscore
SCOR
|
+$28.2M |
| 4 |
KW
Kennedy-Wilson Holdings
KW
|
+$26.6M |
| 5 |
Granite Construction
GVA
|
+$25.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALOG
Analogic Corp
ALOG
|
+$49.9M |
| 2 |
Copart
CPRT
|
+$41M |
| 3 |
HSII
Heidrick & Struggles
HSII
|
+$30M |
| 4 |
CVG
Convergys
CVG
|
+$24.3M |
| 5 |
Children's Place
PLCE
|
+$23.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 30.14% |
| 2 | Technology | 17.94% |
| 3 | Consumer Discretionary | 14.58% |
| 4 | Financials | 12.3% |
| 5 | Materials | 7.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1176
MiMedx Group
MDXG
$674M
| $15K | ﹤0.01% |
2,301
+1,230
| +115% | +$8.76K |
|
1177
NVE Corp
NVEC
$469M
| $15K | ﹤0.01% |
+127
| New | +$12.7K |
|
1178
Omega Flex
OFLX
$265M
| $15K | ﹤0.01% |
184
+65
| +55% | +$4.52K |
|
1179
Cactus
WHD
$4.71B
| $15K | ﹤0.01% |
+442
| New | +$13.7K |
|
|
VIA
1180
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
| $15K | ﹤0.01% |
317
+156
| +97% | +$8.41K |
|
1181
Enanta Pharmaceuticals
ENTA
$366M
| $14K | ﹤0.01% |
122
+17
| +16% | +$1.7K |
|
1182
Nicolet Bankshares
NIC
$3.6B
| $14K | ﹤0.01% |
+255
| New | +$14.3K |
|
1183
QuidelOrtho
QDEL
$751M
| $14K | ﹤0.01% |
+213
| New | +$12.9K |
|
1184
United States Lime & Minerals
USLM
$3.33B
| $13K | ﹤0.01% |
795
+280
| +54% | +$4.38K |
|
1185
Corcept Therapeutics
CORT
$11.9B
| $12K | ﹤0.01% |
+747
| New | +$13K |
|
1186
DHI Group
DHX
$212M
| $12K | ﹤0.01% |
5,026
+309
| +7% | +$625 |
|
1187
Evolution Petroleum
EPM
$135M
| $12K | ﹤0.01% |
1,215
+346
| +40% | +$3.19K |
|
1188
Goldgroup Mining
GORO
$476M
| $12K | ﹤0.01% |
+471
| New | +$10.6K |
|
1189
First Internet Bancorp
INBK
$251M
| $12K | ﹤0.01% |
359
+176
| +96% | +$6.16K |
|
|
USAK
1190
DELISTED
USA Truck Inc
USAK
| $12K | ﹤0.01% |
509
+241
| +90% | +$5.94K |
|
|
XOXO
1191
DELISTED
Xo Group Inc
XOXO
| $12K | ﹤0.01% |
387
+40
| +12% | +$1.12K |
|
|
ABCD
1192
DELISTED
Cambium Learning Group, Inc.
ABCD
| $12K | ﹤0.01% |
1,041
+365
| +54% | +$3.9K |
|
1193
CytomX Therapeutics
CTMX
$628M
| $11K | ﹤0.01% |
499
+274
| +122% | +$7K |
|
|
CTO
1194
CTO Realty Growth
CTO
$783M
| $11K | ﹤0.01% |
682
+317
| +87% | +$5.24K |
|
|
FONR
1195
DELISTED
Fonar
FONR
| $11K | ﹤0.01% |
403
+154
| +62% | +$4.29K |
|
1196
FS Bancorp
FSBW
$345M
| $11K | ﹤0.01% |
340
+126
| +59% | +$3.66K |
|
1197
Simulations Plus
SLP
$372M
| $11K | ﹤0.01% |
482
+125
| +35% | +$2.36K |
|
|
PENG
1198
Penguin Solutions Inc
PENG
$2.4B
| $11K | ﹤0.01% |
+670
| New | +$14.4K |
|
|
JNCE
1199
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $11K | ﹤0.01% |
+1,378
| New | +$19.9K |
|
|
CNCE
1200
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $11K | ﹤0.01% |
667
+344
| +107% | +$6.68K |
|
Similar funds
JF
WRCM
LC
AIM
SC
ERSOT
BAMF
Royce & Associates's Q2 2018 Portfolio in Review
As of Q2 2018, Royce & Associates held 1,321 positions worth $14.5B, up 1.2% from $14.3B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Royce & Associates withdrew a net $486M in Q2 2018, closing 108 positions and reducing 438 holdings. Its most notable exit was Analogic Corp, an estimated $49.9M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 30% of assets, up from 30% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Royce & Associates opened a new position in Comscore worth $26.1M.
- Royce & Associates's largest Q2 2018 buy was Comscore: 59,847 shares worth $26.1M.
- Royce & Associates added most to ProAssurance in Q2 2018, an estimated $42.4M increase.
- Royce & Associates's biggest Q2 2018 reduction was Copart, cutting an estimated $41M.
- Royce & Associates fully exited Analogic Corp in Q2 2018, selling an estimated $49.9M.
- Royce & Associates's ten largest holdings make up 7.9% of its $14.5B portfolio in Q2 2018.
- Royce & Associates opened 67 new positions and closed 108 in Q2 2018.
- Royce & Associates's portfolio value rose 1.2% quarter-over-quarter to $14.5B.
Based on Royce & Associates's 13F filing for Q2 2018, filed 9 Aug 2018.